Literature DB >> 25879297

Negative regulation of the inflammasome: keeping inflammation under control.

Gustavo Pedraza-Alva1, Leonor Pérez-Martínez, Laura Valdez-Hernández, Karla F Meza-Sosa, Masami Ando-Kuri.   

Abstract

In addition to its roles in controlling infection and tissue repair, inflammation plays a critical role in diverse and distinct chronic diseases, such as cancer, metabolic syndrome, and neurodegenerative disorders, underscoring the harmful effect of an uncontrolled inflammatory response. Regardless of the nature of the stimulus, initiation of the inflammatory response is mediated by assembly of a multimolecular protein complex called the inflammasome, which is responsible for the production of inflammatory cytokines, such as interleukin-1β (IL-1β) and IL-18. The different stimuli and mechanisms that control inflammasome activation are fairly well understood, but the mechanisms underlying the control of undesired inflammasome activation and its inactivation remain largely unknown. Here, we review recent advances in our understanding of the molecular mechanisms that negatively regulate inflammasome activation to prevent unwanted activation in the resting state, as well as those involved in terminating the inflammatory response after a specific insult to maintain homeostasis.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Caspase-1; IL-18; IL-1β; NLRP; inflammasome; inflammation

Mesh:

Substances:

Year:  2015        PMID: 25879297     DOI: 10.1111/imr.12294

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  23 in total

Review 1.  Molecular mechanisms regulating NLRP3 inflammasome activation.

Authors:  Eun-Kyeong Jo; Jin Kyung Kim; Dong-Min Shin; Chihiro Sasakawa
Journal:  Cell Mol Immunol       Date:  2015-11-09       Impact factor: 11.530

2.  The inflammasome: firing up innate immunity.

Authors:  Thirumala-Devi Kanneganti
Journal:  Immunol Rev       Date:  2015-05       Impact factor: 12.988

3.  SERPINB1-mediated checkpoint of inflammatory caspase activation.

Authors:  Youn Jung Choi; Stephanie Kim; Younho Choi; Travis B Nielsen; Jun Yan; Alvin Lu; Jianbin Ruan; Hye-Ra Lee; Hao Wu; Brad Spellberg; Jae U Jung
Journal:  Nat Immunol       Date:  2019-01-28       Impact factor: 25.606

4.  Tibolone Reduces Oxidative Damage and Inflammation in Microglia Stimulated with Palmitic Acid through Mechanisms Involving Estrogen Receptor Beta.

Authors:  Oscar Hidalgo-Lanussa; Marco Ávila-Rodriguez; Eliana Baez-Jurado; Jairo Zamudio; Valentina Echeverria; Luis Miguel Garcia-Segura; George E Barreto
Journal:  Mol Neurobiol       Date:  2017-09-25       Impact factor: 5.590

5.  NLRP3 inflammasome signaling is activated by low-level lysosome disruption but inhibited by extensive lysosome disruption: roles for K+ efflux and Ca2+ influx.

Authors:  Michael A Katsnelson; Kristen M Lozada-Soto; Hana M Russo; Barbara A Miller; George R Dubyak
Journal:  Am J Physiol Cell Physiol       Date:  2016-05-11       Impact factor: 4.249

6.  [Dexmedetomidine preconditioning alleviates acute lung injury induced by intestinal ischemia-reperfusion in rats by inhibiting NLRP3 inflammasome activation].

Authors:  B Han; M Chen; C Yang; X Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-12-20

7.  Hemin and Cobalt Protoporphyrin Inhibit NLRP3 Inflammasome Activation by Enhancing Autophagy: A Novel Mechanism of Inflammasome Regulation.

Authors:  Katariina Nurmi; Ilona Kareinen; Juhani Virkanen; Kristiina Rajamäki; Vesa-Petteri Kouri; Kirsi Vaali; Anna-Liisa Levonen; Nanna Fyhrquist; Sampsa Matikainen; Petri T Kovanen; Kari K Eklund
Journal:  J Innate Immun       Date:  2016-09-22       Impact factor: 7.349

8.  Shigella hijacks the glomulin-cIAPs-inflammasome axis to promote inflammation.

Authors:  Shiho Suzuki; Toshihiko Suzuki; Hitomi Mimuro; Tsunehiro Mizushima; Chihiro Sasakawa
Journal:  EMBO Rep       Date:  2017-11-30       Impact factor: 8.807

Review 9.  The Signaling Pathways Regulating NLRP3 Inflammasome Activation.

Authors:  Ming-Ye Chen; Xun-Jia Ye; Xian-Hui He; Dong-Yun Ouyang
Journal:  Inflammation       Date:  2021-05-19       Impact factor: 4.092

10.  NLRC4 inhibits NLRP3 inflammasome and abrogates effective antifungal CD8+ T cell responses.

Authors:  Camila O S Souza; Natália Ketelut-Carneiro; Cristiane M Milanezi; Lúcia H Faccioli; Luiz G Gardinassi; João S Silva
Journal:  iScience       Date:  2021-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.